Literature DB >> 25848760

A common variant of ubiquinol-cytochrome c reductase complex is associated with DDH.

Ye Sun1, Cheng Wang2, Zheng Hao3, Jin Dai1, Dongyang Chen3, Zhihong Xu3, Dongquan Shi1, Ping Mao3, Huajian Teng4, Xiang Gao2, Zhibin Hu5, Hongbing Shen5, Qing Jiang1.   

Abstract

PURPOSE: Genetic basis of Developmental dysplasia of the hip (DDH) remains largely unknown. To find new susceptibility genes for DDH, we carried out a genome-wide association study (GWAS) for DDH.
METHODS: We enrolled 386 radiology confirmed DDH patients and 558 healthy controls (Set A) to conduct a genome-wide association study (GWAS). Quality-control was conducted at both the sample and single nucleotide polymorphism (SNP) levels. We then conducted a subsequent case-control study to replicate the association between a promising loci, rs6060373 in UQCC gene and DDH in an independent set of 755 cases and 944 controls (set B).
RESULTS: In the DDH GWAS discovering stage, 51 SNPs showed significance of less than 10-4, and another 577 SNPs showed significance of less than 10-3. In UQCC, all the 12 genotyped SNPs showed as promising risk loci. Genotyping of rs6060373 in set A showed the minor allele A as a promising risk allele (p = 4.82*10-7). In set A, the odds ratio of allele A was 1.77. Genotyping of rs6060373 in Set B produced another significant result (p = 0.0338) with an odds ratio of 1.18 for risk allele A. Combining set A and set B, we identified a total p value of 3.63*10-6 with the odds ratio of 1.35 (1.19-1.53) for allele A.
CONCLUSION: Our study demonstrates common variants of UQCC, specifically rs6060373, are associated with DDH in Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25848760      PMCID: PMC4388640          DOI: 10.1371/journal.pone.0120212

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Developmental dysplasia of the hip (DDH, OMIM #142700) is one common skeletal disorder, presenting with shallow acetabulum and decreased coverage of the femoral head. [1] Incidence of DDH varies from 0.1% to 1.84% in Caucasian population, and 0.1%-0.5% in Chinese population. [2] Persistent DDH can induce chronic hip pain, dysfunction and increase the hip osteoarthritis risk. [3] DDH is a polygenic disease with both environmental and genetic risk factors. [4] Though Mechanical factors (e.g. breech delivery, high birth weight, primiparity and oligoamnios) are suggested [5,6], it is accepted that genetic components are a crucial part in the etiology of DDH. Several DDH susceptibility genes (e.g. GDF5, TBX4, ASPN and PAPPA2) were discovered by association study in Chinese and Caucasian populations [7-10]. However, the genetic basis of DDH remains largely unknown. Genome-wide association study (GWAS) is a genetic method for explaining complex human diseases such as osteoarthritis [11,12]. GWAS has the potential to identify new susceptibility genes with previously unknown function and their relationship to the disorder. Susceptibility genes for several common skeletal disorders have been identified by using this approach[11-13]. In order to find new susceptibility genes for DDH, we carried out a genome-wide association study for DDH. Within our GWAS result, we found 12 variants in Ubiquinol-cytochrome c reductase complex chaperone (UQCC) gene associated with DDH (Table 1).
Table 1

Identified SNPs in UQCC gene in the genome-wide analysis.

Case GenotypeControl GenotypeTest for allele frequency
dbSNP IDChrome Position111222SumAllele 2 frequency111222SumAllele 2 frequencyP ValueOdds ratio(95% CI)
rs6060355 33890061259110173860.187286226465580.2850.000001041.74(1.39–2.17)
rs878639 33894463259110173860.187284228465580.2870.000003491.75(1.40–2.91)
rs1406948 33905619260109173860.185286226465580.2850.000003961.75(1.40–2.19)
rs6088791 33907909260109173860.185285226465570.2850.0000006571.76(1.41–2.20)
rs6060371 33913322260107183850.186286225475580.2860.0000006931.75(1.40–2.19)
rs6060373 33914208260109173860.185285226475580.2870.0000004821.77(1.41–2.21)
rs4911178 33952620258111173860.188285227465580.2860.000001191.73(1.39–2.16)
rs60696658 33954913258110173850.187286223485570.2860.0000008771.74(1.40–2.18)
rs4911494 33971914259110173860.187286226465580.2850.000001041.74(1.39–2.17)
rs6088813 33975181259110173860.187284226465560.2860.0000008321.75(1.40–2.18)
rs6087704 34001058259110173860.187286226465580.2850.000001041.74(1.39–2.17)
rs6087705 34001250259110173860.187286226465580.2850.000001041.74(1.39–2.17)

Population set A was genotyped. Allele 1 and allele 2 indicate the major and minor allele in the DDH population, respectively, and 11, 12 and 22 indicate homozygote of allele 1 and heterozygote and homozygote of allele 2, respectively. Odds ratio shown is for allele 1 versus allele 2.

Population set A was genotyped. Allele 1 and allele 2 indicate the major and minor allele in the DDH population, respectively, and 11, 12 and 22 indicate homozygote of allele 1 and heterozygote and homozygote of allele 2, respectively. Odds ratio shown is for allele 1 versus allele 2. UQCC encodes a zinc-binding protein, putatively repressed by fibroblast growth factor 2 (FGF2), which functions with several genes in morphogenesis and growth of skeleton. [14,15] UQCC is expressed in differentiating chondrocytes,[16] and is first expressed at early stages of mesenchymal cell proliferation in mouse.[17] UQCC has been reported as an important candidate gene in genome-wide association studies for spine bone size, height and testicular germ cell tumors.[18-20] Based on the importance of UQCC in chondrogenesis, we thought UQCC could be an attractive candidate gene of DDH, and then conducted a subsequent case-control study to evaluate the association between UQCC gene and DDH, and found UQCC was associated with DDH

Materials and Methods

Patients

We enrolled 386 radiology confirmed DDH patients and 558 healthy controls (Set A) to conduct a case-control genome-wide association study (GWAS). DDH patients were consecutively recruited from the Center of Diagnosis and Treatment for Development dysplasia of hip, Kang’ai Hospital. Controls were recruited from the First Affiliated Hospital of Nanjing Medical University and the Affiliated Nanjing Children's Hospital of Nanjing Medical University (Nanjing, China) between March 2006 and March 2009. An independent set of up to 755 cases and 944 controls (set B) were applied for replication of the most promising loci. DDH patients were also consecutively recruited from the Center of Diagnosis and Treatment for Development dysplasia of hip, Kang’ai Hospital. Controls were enrolled at the Physical Examination Center, Drum Tower Hospital, affiliated to the Medical School of Nanjing University. The diagnosis of DDH was made on the basis of clinical criteria and radiographic evidence by experts. All controls had no symptom or history of DDH. Subjects with any systemic syndrome were excluded. All the subjects were Han Chinese living in or around Nanjing. The study was approved by the ethical committee of the Nanjing University and the ethical committee of Nanjing Medical University, and written informed consent was obtained from all patients and controls. Written informed consent was obtained from guardians on behalf of the minors/children enrolled in this study.

Methods

DNA was extracted from all the subjects either from peripheral blood using the NucleoSpin Blood QuickPure Kit (Macherey-Nagel GmbH & Co. KG, Düren, German) or buccal swabs using the DNA IQ System (Promega, Madison, WI) according to the manufacture’s protocol. The set A samples were genotyped by using Illumina Human Omni ZhongHua-8BeadChips (Illumina, San Diego, CA, USA). Quality-control was conducted at both the sample and single nucleotide polymorphism (SNP) levels (S1 Fig). We performed case-control analysis for all the SNPs in set A. From the primary result, we found a region at 20q11.22 was significantly associated with DDH. 21 SNPs in the region showed significance. To check the most promising loci, set B samples were genotyped by Taqman assay. The samples were genotyped by laboratory personnel blinded to case status. Genotyping, data entry and statistical analyses results were reviewed by two authors independently. Five percent samples were randomly selected to duplicate and yielded a 100% concordance.

Statistics

The SAS software (version 9.2—SAS Institute, Cary, NC, USA) was used to test the association between DDH patients and control subjects. First of all, two-sided chi-squared tests were performed to determine the significance of differences in allelic frequencies and P<0.05 was considered statistically significant for Set B. The data of set A and set B was then combined using an additive, 2-tailed Cochran-Mantel-Haenszel model. Hardy-Weinberg equilibrium was calculated by chi-squared test in both control and case groups.

Results

In the DDH GWAS discovering stage, associations were assessed in an additive model using logistic regression analyses with adjustment for the top eigenvector (). 51 SNPs showed significance of less than 10–4, and another 577 SNPs showed significance of less than 10–3 (S1 Table). From these 628 SNPs we found 21 SNPs at a same region, 20q11.22. UQCC and GDF5 genes located in this region. GDF5 was previously reported as DDH susceptibility gene by our group. [7] In UQCC, all the 12 genotyped SNPs showed promising difference of allele frequencies. Details of the genotypes and allele distributions of cases and controls of the 12 SNPs were listed in Table 1. All of them showed significance of less than 5*10–6, with similar odds ratios ranging from 1.73 to 1.77 for the risk alleles (Table 1) rs6060373 was reported to be associated with body measurement traits and osteoarthritis, [18] and linkage Disequilibrium tests demonstrated rs6060373 had D’ value>0.9 to all the other 11 SNPs within UQCC. (S2 Fig) So we chose rs6060373 as the most promising locus and conducted a case-control analysis in an independent set of subjects (set B).

Genome-wide association results for DDH in Han Chinese populations.

Scatter plot of P values on a —log10 scale from the logistic regression model in an additive model with adjustment for the top eigenvector. The green horizontal line represents P = 1.0 × 10–4. Distributions of genotypes of rs6060373 in both case and control groups were conformed to Hardy-Weinberg equilibrium in both set A and set B (p>0.1). Genotyping of rs6060373 in set A showed the minor allele A as a promising risk allele (p = 4.82*10–7). In set A, the odds ratio of allele A was 1.77 (Table 1). Genotyping of rs6060373 in another independent population consisting of 755 cases and 944 controls (Set B) produced another significant result (p = 0.0338) with an odds ratio of 1.18 for risk allele A (Table 2). Combining set A and set B, we identified a total p value of 3.63*10–6 with the odds ratio of 1.35 (1.19–1.53) for allele A.
Table 2

Association of rs6060373 in UQCC gene with DDH.

PopulationCaseControlP value for allele frequencyOdds ratio (95% CI)
GenotypeAllele G frequencyGenotypeAllele G frequency
AAAGGGSumAAAGGGSum
Set A 260109173860.19285226475580.29 4.82*10 –7 1.77(1.41–2.21)
Set B 426293367550.24500371739440.27 0.0338 1.18(1.01–1.38)
Set A + Set B # 6864025311410.2278559712015020.28 3.63*10 –6 1.35(1.19–1.53)

Odds ratio shown is for allele A versus allele G.

#Set A and Set B were combined using an additive, 2-tailed Cochran-Mantel-Haenszel model.

Odds ratio shown is for allele A versus allele G. #Set A and Set B were combined using an additive, 2-tailed Cochran-Mantel-Haenszel model.

Discussion

We conducted the first GWAS for DDH and identified a new DDH susceptibility gene UQCC. Important roles of UQCC have been revealed in body measurement traits (e.g. height, skeletal frame and spine size) and osteoarthritis. [18] rs6060373 was highlighted in previous reports, and it had D’ value>0.9 to other 11 SNPs in UQCC. [21] So we chose rs6060373 for replication study on behalf of other 11 SNPs in UQCC, and it appeared to be a risk locus for DDH. UQCC encodes a zinc-binding protein as a chaperone in mitochondrial respiratory chain to assembly Ubiquinol-cytochrome c reductase, of which activity is reduced in yeast lacking UQCC. [22] Interestingly, activity of ubiquinol-cytochrome c reductase is significantly reduced in cultured osteoarthritic chondrocytes compared to normal chondrocytes.[23] UQCC is identified as a target gene of FGF2 using induction gene trap approach in embryonic stem cells. FGF2 plays a vital role in chondrogenesis. [24] Overexpression of FGF2 results in dyschondroplasia and hence dwarfism in mice while FGF2 knock-out mice will have decreased bone density and develop accelerated osteoarthritis. [25-28] UQCC, repressed by FGF2, is likely to be involved in regulation of skeletal development and chondrogenesis by FGF2. However, further studies are needed to reveal its specific functional role in growth. In conclusion, our study demonstrates common variants of UQCC, specifically rs6060373, are associated with DDH in Han Chinese population.

Quality-control was conducted at both the sample and single nucleotide polymorphism (SNP) levels as illustrated.

(JPG) Click here for additional data file.

Linkage Disequilibrium tests demonstrated all 12 SNPs within UQCC gene had a D’ value>0.9 to rs6060373.

(JPG) Click here for additional data file.

Summary of loci associated with DDH in GWAS discovering stages.

(DOCX) Click here for additional data file.
  28 in total

1.  Report of the delegation of clinical geneticists to China, Spring 1986.

Authors:  M Laurence; P S Harper; R Harris; N C Nevin; D F Roberts
Journal:  Biol Soc       Date:  1987-06

2.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  A two-locus model for non-syndromic congenital dysplasia of the hip (CDH).

Authors:  V Sollazzo; G Bertolani; E Calzolari; G Atti; C Scapoli
Journal:  Ann Hum Genet       Date:  2000-01       Impact factor: 1.670

4.  Genetic and environmental factors in the etiology of congenital dislocation of the hip.

Authors:  C O Carter; J A Wilkinson
Journal:  Clin Orthop Relat Res       Date:  1964 Mar-Apr       Impact factor: 4.176

5.  Expression of a novel mouse gene 'mbFZb' in distinct regions of the developing nervous system and the adult brain.

Authors:  K Vetter; W Wurst
Journal:  Mech Dev       Date:  2001-01       Impact factor: 1.882

6.  Identification and characterization of a new gene (CBP3) required for the expression of yeast coenzyme QH2-cytochrome c reductase.

Authors:  M Wu; A Tzagoloff
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

7.  Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation.

Authors:  Henning Madry; Greg Emkey; David Zurakowski; Stephen B Trippel
Journal:  J Gene Med       Date:  2004-02       Impact factor: 4.565

8.  Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis.

Authors:  Hideaki Imabayashi; Taisuke Mori; Satoshi Gojo; Tohru Kiyono; Tomoyasu Sugiyama; Ryotaro Irie; Takao Isogai; Jun-ichi Hata; Yoshiaki Toyama; Akihiro Umezawa
Journal:  Exp Cell Res       Date:  2003-08-01       Impact factor: 3.905

9.  Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes.

Authors:  Emilia Maneiro; Miguel A Martín; María C de Andres; Maria J López-Armada; José L Fernández-Sueiro; Pilar del Hoyo; Fausto Galdo; Joaquin Arenas; Francisco J Blanco
Journal:  Arthritis Rheum       Date:  2003-03

10.  STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2.

Authors:  M Sahni; R Raz; J D Coffin; D Levy; C Basilico
Journal:  Development       Date:  2001-06       Impact factor: 6.868

View more
  10 in total

1.  Comprehensive bioinformatics analysis of susceptibility genes for developmental dysplasia of the hip.

Authors:  Wei Yang; Guiyang Jin; Keying Qian; Chao Zhang; Wei Zhi; Dan Yang; Yanqin Lu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2022-05

2.  The Association Between BMP-2, UQCC1 and CX3CR1 Polymorphisms and the Risk of Developmental Dysplasia of the Hip.

Authors:  Evren Gumus; Ebru Temiz; Baran Sarikaya; Ozgur Yuksekdag; Serkan Sipahioglu; Ataman Gonel
Journal:  Indian J Orthop       Date:  2020-08-29       Impact factor: 1.251

3.  Genome-wide association study of developmental dysplasia of the hip identifies an association with GDF5.

Authors:  Konstantinos Hatzikotoulas; Andreas Roposch; Karan M Shah; Matthew J Clark; Selina Bratherton; Vasanti Limbani; Julia Steinberg; Eleni Zengini; Kaltuun Warsame; Madhushika Ratnayake; Maria Tselepi; Jeremy Schwartzentruber; John Loughlin; Deborah M Eastwood; Eleftheria Zeggini; J Mark Wilkinson
Journal:  Commun Biol       Date:  2018-05-31

4.  Heterozygous LRP1 deficiency causes developmental dysplasia of the hip by impairing triradiate chondrocytes differentiation due to inhibition of autophagy.

Authors:  Wenjin Yan; Liming Zheng; Xingquan Xu; Zheng Hao; Yibo Zhang; Jun Lu; Ziying Sun; Jin Dai; Dongquan Shi; Baosheng Guo; Qing Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

Review 5.  Developmental Dysplasia of the Hip: A Review of Etiopathogenesis, Risk Factors, and Genetic Aspects.

Authors:  Stefan Harsanyi; Radoslav Zamborsky; Lubica Krajciova; Milan Kokavec; Lubos Danisovic
Journal:  Medicina (Kaunas)       Date:  2020-03-31       Impact factor: 2.430

6.  The role of Gdf5 regulatory regions in development of hip morphology.

Authors:  Ata M Kiapour; Jiaxue Cao; Mariel Young; Terence D Capellini
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

Review 7.  Developmental dysplasia of the hip: a systematic literature review of the genes related with its occurrence.

Authors:  Ioannis Gkiatas; Anastasia Boptsi; Dimitra Tserga; Ioannis Gelalis; Dimitrios Kosmas; Emilios Pakos
Journal:  EFORT Open Rev       Date:  2019-10-01

8.  3D-bioprinting a genetically inspired cartilage scaffold with GDF5-conjugated BMSC-laden hydrogel and polymer for cartilage repair.

Authors:  Ye Sun; Yongqing You; Wenbo Jiang; Zanjin Zhai; Kerong Dai
Journal:  Theranostics       Date:  2019-09-21       Impact factor: 11.556

9.  Joint disease-specificity at the regulatory base-pair level.

Authors:  Pushpanathan Muthuirulan; Dewei Zhao; Mariel Young; Daniel Richard; Zun Liu; Alireza Emami; Gabriela Portilla; Shayan Hosseinzadeh; Jiaxue Cao; David Maridas; Mary Sedlak; Danilo Menghini; Liangliang Cheng; Lu Li; Xinjia Ding; Yan Ding; Vicki Rosen; Ata M Kiapour; Terence D Capellini
Journal:  Nat Commun       Date:  2021-07-06       Impact factor: 14.919

Review 10.  The Genetic Epidemiology of Joint Shape and the Development of Osteoarthritis.

Authors:  J Mark Wilkinson; Eleftheria Zeggini
Journal:  Calcif Tissue Int       Date:  2020-05-11       Impact factor: 4.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.